Thomas Fleischer

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Integrated multi-omics profiling uncovers the epigenetic, transcriptional, and metabolic landscape of prostate cancer progression.

Integrated multi-omics profiling uncovers the epigenetic, transcriptional, and metabolic landscape of prostate cancer progression.

Journal: BMC cancer

Published: March 24, 2026

Molecular profiling of chemotherapy-resistant breast cancer reveals DNA methylation remodeling associated with the acquisition of paclitaxel resistance.

Molecular profiling of chemotherapy-resistant breast cancer reveals DNA methylation remodeling associated with the acquisition of paclitaxel resistance.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: May 26, 2025

DNA methylation in normal-appearing tissue associated with prostate cancer recurrence and metastasis.

DNA methylation in normal-appearing tissue associated with prostate cancer recurrence and metastasis.

Journal: Clinical epigenetics

Published: December 23, 2024

Integrative pan-cancer analysis reveals a common architecture of dysregulated transcriptional networks characterized by loss of enhancer methylation.

Integrative pan-cancer analysis reveals a common architecture of dysregulated transcriptional networks characterized by loss of enhancer methylation.

Journal: PLoS computational biology

Published: February 20, 2024

Multi-omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma.

Multi-omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma.

Journal: International journal of cancer

Published: September 01, 2023

MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients.

MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients.

Journal: Cancers

Published: August 02, 2023

Telomere length as a predictor of therapy response and survival in patients diagnosed with ovarian carcinoma.

Telomere length as a predictor of therapy response and survival in patients diagnosed with ovarian carcinoma.

Journal: Heliyon

Published: July 18, 2023

An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer.

An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer.

Journal: Molecular oncology

Published: July 11, 2023

ABCB1 Amplicon Contains Cyclic AMP Response Element-Driven TRIP6 Gene in Taxane-Resistant MCF-7 Breast Cancer Sublines.

ABCB1 Amplicon Contains Cyclic AMP Response Element-Driven TRIP6 Gene in Taxane-Resistant MCF-7 Breast Cancer Sublines.

Journal: Genes

Published: December 12, 2022

Complex molecular profile of DNA repair genes in epithelial ovarian carcinoma patients with different sensitivity to platinum-based therapy.

Complex molecular profile of DNA repair genes in epithelial ovarian carcinoma patients with different sensitivity to platinum-based therapy.

Journal: Frontiers in oncology

Published: August 11, 2022

Transcriptomic pan-cancer analysis using rank-based Bayesian inference.

Transcriptomic pan-cancer analysis using rank-based Bayesian inference.

Journal: Molecular oncology

Published: July 01, 2022

PHLPP1 regulates CFTR activity and lumen expansion through AMPK.

PHLPP1 regulates CFTR activity and lumen expansion through AMPK.

Journal: Development (Cambridge, England)

Published: May 16, 2022

Showing 1-12 of 46

Last Updated: 09/26/2026